Search

everythinglearnresearchcommunity

for

Search:↓

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

LC-OCT is a promising tool for diagnosing and monitoring Alopecia areata.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Alopecia areata incognita causes widespread hair loss without patches and needs a scalp biopsy for diagnosis.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

308 nm excimer phototherapy can help some people with alopecia areata regrow hair, especially if their condition is less severe.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

Combining nonablative fractional laser with minoxidil was effective for alopecia areata with only one patient relapsing after a year.

Targeting CXCL10 may help treat alopecia areata.

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.

Alopecia areata affects hair follicle structure, even in non-balding areas.

Topical minoxidil did not significantly regrow hair in alopecia areata patients after 3 months.

PUVA treatment led to significant hair regrowth in over half of the patients with alopecia areata totalis and universalis.

Higher levels of IL-1a and IL-1RA were found in severe alopecia areata cases.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

The 308-nm excimer laser helps hair regrowth in some alopecia areata cases but not all.

Trichoscopy shows black dots, yellow dots, and empty follicles are common in Alopecia Areata, with broken and exclamation mark hair as typical patterns.

New treatments for alopecia areata show promise, but no cure exists and responses to treatments vary.

Early treatment and multidisciplinary care are key to managing Frontal Fibrosing Alopecia and preventing further hair loss.

Treatments for autoimmune hair loss have limited success and patients need emotional support and self-acceptance.

Temporal triangular alopecia is a non-scarring hair loss in children, often linked to other health conditions.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

A dog with complete hair loss regrew most hair after treatment, with no relapse after stopping treatment.